Knockin mouse models demonstrate differential contributions of synaptotagmin-1 and -2 as receptors for botulinum neurotoxins.
Botulinum neurotoxins (BoNTs) are the most potent toxins known and are also utilized to treat a wide range of disorders including muscle spasm, overactive bladder, and pain. BoNTs' ability to target neurons determines their specificity, potency, and therapeutic efficacy. Homologous synaptic ves...
Guardado en:
Autores principales: | Hatim Thaker, Jie Zhang, Shin-Ichiro Miyashita, Vivian Cristofaro, SunHyun Park, Ali Hashemi Gheinani, Maryrose P Sullivan, Rosalyn M Adam, Min Dong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3cf69e782b1546cfb49dd11df51d67a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification and characterization of a novel botulinum neurotoxin
por: Sicai Zhang, et al.
Publicado: (2017) -
On Botulinum Neurotoxin Variability
por: Cesare Montecucco, et al.
Publicado: (2015) -
Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
por: Liang Tao, et al.
Publicado: (2017) -
Neurologic uses of botulinum neurotoxin type A
por: John P Ney, et al.
Publicado: (2007) -
Recombinant botulinum neurotoxin serotype A1 in vivo characterization
por: Cindy Périer, et al.
Publicado: (2021)